Zydus Lifesciences will consider raising up to ₹5,000 crore via multiple routes, including QIP and rights issue, as it prepares to announce its Q2 results.
Zydus Lifesciences will consider raising up to ₹5,000 crore via multiple routes, including QIP and rights issue, as it prepares to announce its Q2 results.